Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
46.14 USD | +0.48% | -0.80% | -29.33% |
Nov. 02 | Gentherm Launching $60 Million Accelerated Share Repurchase; Shares Rise | MT |
Oct. 27 | Craig-Hallum Cuts Price Target on Gentherm to $70 From $80, Maintains Buy Rating | MT |
Financials (USD)
Sales 2023 * | 1,457 M | Sales 2024 * | 1,574 M | Capitalization | 1,513 M |
---|---|---|---|---|---|
Net income 2023 * | 38.00 M | Net income 2024 * | 86.00 M | EV / Sales 2023 * | 1,10x |
Net Debt 2023 * | 85.28 M | Net Debt 2024 * | 133 M | EV / Sales 2024 * | 1,05x |
P/E ratio 2023 * | 41,0x | P/E ratio 2024 * | 17,7x | Employees | 14,568 |
Yield 2023 * | - | Yield 2024 * | - | Free-Float | 98.45% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
1 day | +0.48% | ||
1 week | -0.80% | ||
Current month | +0.48% | ||
1 month | +7.60% | ||
3 months | -23.61% | ||
6 months | -19.31% | ||
Current year | -29.33% |
1 week
44.78
47.50

1 month
42.31
48.35

Current year
38.21
76.13

1 year
38.21
76.13

3 years
38.21
99.00

5 years
27.24
99.00

10 years
22.84
99.00

Managers | Title | Age | Since |
---|---|---|---|
Phillip M. Eyler
CEO | Chief Executive Officer | 51 | 2017 |
Matteo Anversa
DFI | Director of Finance/CFO | 52 | 2018 |
Rafael Barkas
COO | Chief Operating Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Heinzmann
BRD | Director/Board Member | 59 | 2020 |
Chairman | 64 | 2016 | |
Charles Kummeth
BRD | Director/Board Member | 62 | 2018 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.08% | 11 M€ | +18.11% | - | |
2.95% | 4 M€ | -8.42% | - | |
2.52% | 21 M€ | -12.73% | ||
2.52% | 1 M€ | 0.00% | ||
2.52% | 1 M€ | 0.00% |
Date | Price | Change | Volume |
---|---|---|---|
23-12-01 | 46.14 | +0.48% | 203,492 |
23-11-30 | 45.92 | -0.46% | 171,012 |
23-11-29 | 46.13 | -0.17% | 147,886 |
23-11-28 | 46.21 | -0.32% | 114,090 |
23-11-27 | 46.36 | -0.32% | 125,724 |
Delayed Quote Nasdaq, December 01, 2023 at 04:00 pm EST
More quotes
Gentherm Incorporated is a developer, manufacturer, and marketer of thermal management technologies for a range of heating and cooling and temperature control applications in the automotive and medical industries. Its segments include Automotive and Medical. The Automotive segment represents the design, development, manufacturing and sales of automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronic and software systems. Its climate comfort systems include seat heaters, blowers, and thermoelectric devices. The Medical segment is comprised of the results from the patient temperature management business in the medical industry. Patient temperature management includes temperature management systems across multiple product categories addressing the needs of hyper-hypothermia therapy in intensive care, normothermia in surgical procedures and additional warming/cooling therapies utilized in acute care, ambulatory, and clinics.
Calendar
2024-02-20
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
B
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
46.14USD
Average target price
61.75USD
Spread / Average Target
+33.83%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.33% | 1 513 M $ | |
+42.75% | 47 456 M $ | |
-9.79% | 23 763 M $ | |
+28.44% | 16 385 M $ | |
-1.20% | 15 940 M $ | |
+13.22% | 15 699 M $ | |
+27.62% | 15 519 M $ | |
+6.76% | 13 335 M $ | |
+56.26% | 10 098 M $ | |
+22.86% | 9 792 M $ |